Physician profile
Azeem Khan
NPI 1780245266
$2,014.95
in general payments reported to CMS, 2019-2025
10 companies · $21.80 in 2025
The $21.80 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.39 · 2021: $178 · 2022: $689 · 2023: $737 · 2024: $366 · 2025: $21.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812 · Travel and Lodging: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $811.77 |
| Travel and Lodging | $312.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $875.84 | 2022-2023 | Clareon, Dailies Total1, Total30 |
| Bausch & Lomb Americas INC. | $342.81 | 2022-2024 | Stellaris |
| Sight Sciences, INC. | $249.89 | 2021-2022 | |
| Allergan, INC. | $141.62 | 2020-2022 | |
| Abbvie INC. | $138.56 | 2022-2023 | |
| Genentech USA, INC. | $82.61 | 2024-2025 | Vabysmo |
| Regeneron Healthcare Solutions, INC. | $74.31 | 2022 | |
| Novartis Pharmaceuticals Corporation | $54.11 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $41.07 | 2021 | |
| Carl Zeiss Meditec Cataract Technology INC. | $14.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Azeem Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.